Valuation: Revvity, Inc.

Capitalization 13.66B 13.01B 12.27B 10.83B 19.36B 1,184B 21.48B 146B 54.11B 495B 51.22B 50.18B 2,078B P/E ratio 2024
50.7x
P/E ratio 2025 * 46.8x
Enterprise value 15.62B 14.87B 14.03B 12.39B 22.13B 1,353B 24.56B 167B 61.88B 566B 58.57B 57.39B 2,376B EV / Sales 2024
5.65x
EV / Sales 2025 * 5.43x
Free-Float
99.71%
Yield 2024 *
0.25%
Yield 2025 * 0.24%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.55%
1 week-5.55%
Current month-11.00%
1 month-7.02%
3 months-3.27%
6 months-4.41%
Current year+0.58%
More quotes
1 week
109.76
Extreme 109.76
118.26
1 month
109.76
Extreme 109.76
128.29
Current year
109.76
Extreme 109.76
128.29
1 year
97.32
Extreme 97.315
129.50
3 years
79.50
Extreme 79.5
184.75
5 years
62.91
Extreme 62.91
203.16
10 years
39.50
Extreme 39.5
203.16
More quotes
Director TitleAgeSince
Chief Executive Officer 60 2019-12-29
Director of Finance/CFO 36 2022-09-05
Chief Tech/Sci/R&D Officer - -
Manager TitleAgeSince
Chairman 67 2019-12-29
Director/Board Member 73 2012-02-06
Director/Board Member 71 2016-07-26
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-0.55%-5.55%+8.40%-38.02% 13.66B
+0.70%+2.16%+56.00%+111.83% 212B
-0.15%-6.93%-2.99%-5.23% 203B
-0.03%+0.82%+60.89%+148.33% 156B
+1.33%-0.22%-16.81%-24.01% 148B
-1.21%+1.92%+6.66%+3.50% 67.37B
+0.25%+8.30%-11.45%-29.28% 44.94B
-0.53%+4.58%-15.60%-15.35% 43.65B
-1.36%+5.21%+10.87% - 42.17B
-1.30%-7.26%+1.84%-0.40% 38.42B
Average -0.28%-0.48%+9.78%+16.82% 97.08B
Weighted average by Cap. +0.11%-0.95%+18.76%+43.12%
See all sector performances

Financials

2024 2025 *
Net sales 2.75B 2.62B 2.47B 2.18B 3.9B 239B 4.33B 29.44B 10.91B 99.74B 10.32B 10.11B 419B 2.83B 2.7B 2.54B 2.25B 4.01B 245B 4.45B 30.28B 11.22B 103B 10.62B 10.4B 431B
Net income 272M 259M 244M 215M 385M 23.54B 427M 2.91B 1.08B 9.84B 1.02B 998M 41.32B 278M 264M 249M 220M 393M 24.06B 437M 2.97B 1.1B 10.06B 1.04B 1.02B 42.23B
Net Debt 1.96B 1.87B 1.76B 1.55B 2.78B 170B 3.08B 20.96B 7.77B 71.02B 7.35B 7.2B 298B 1.73B 1.64B 1.55B 1.37B 2.45B 150B 2.72B 18.46B 6.84B 62.56B 6.47B 6.34B 263B
More financial data * Estimated data
Logo Revvity, Inc.
Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows: - medical diagnosis equipment (61%); - analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).
Employees
11,000
Calendar
More about the company
Date Price Change Volume
25-02-14 112.26 $ -0.55% 793,480
25-02-13 112.88 $ +1.45% 770,070
25-02-12 111.27 $ -1.20% 926,044
25-02-11 112.62 $ -1.93% 1,159,226
25-02-10 114.84 $ -3.38% 1,394,174

Delayed Quote Nyse, February 14, 2025 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
112.26USD
Average target price
141.19USD
Spread / Average Target
+25.77%
Consensus

Quarterly revenue - Rate of surprise